Skip to main content
Top
Published in: Acta Diabetologica 1/2010

01-03-2010 | Original Article

Profile of patients with diabetes in Eritrea: results of first phase registry analyses

Authors: Berhane Seyum, Goitom Mebrahtu, Abdulmumini Usman, Jacob Mufunda, Beyene Tewolde, Solomon Haile, Andrew Kosia, Ermias Negassi

Published in: Acta Diabetologica | Issue 1/2010

Login to get access

Abstract

A cross-sectional descriptive study was done on patients recently entered into the National Diabetes Registry in Eritrea where the prevalence was estimated to be 2.2% based on patient information in 2004. Of the 627 patients with diabetes, two thirds were type 2. Although type 1 had poorer control (42.9%) than type 2 (29.9%), some of the risk factors such as cholesterol (43.4 vs. 28.2%), triglyceride (23.4 vs. 12.8%), hypertension (55.2 vs. 12.7%) as well as BMI and waist/hip ratio were higher in type 2 than type 1. More than one-third (41.2%) of patients with type 2 compared to type 1 (19.5%) had complications, the commonest being retinopathy (33%) followed by foot ulcers (14%) and neuropathy (4%). Many of the diabetic patients demonstrated the presence of the metabolic syndrome components such as hypertension, obesity and dyslipidemia. The authors conclude that diabetes registry is invaluable in providing evidence-based prevention and control of the disease.
Literature
1.
go back to reference Adeghate E, Schattner P, Dunn E (2006) An update on the etiology and epidemiology of diabetes mellitus. Ann New York Acad Sci 1084:1–29CrossRef Adeghate E, Schattner P, Dunn E (2006) An update on the etiology and epidemiology of diabetes mellitus. Ann New York Acad Sci 1084:1–29CrossRef
2.
go back to reference Mbanya JC, Sobngwi E (2003) Diabetes in Africa diabetes micro vascular and macro vascular disease in Africa. J Cardiovasc Risk 10:97–102CrossRefPubMed Mbanya JC, Sobngwi E (2003) Diabetes in Africa diabetes micro vascular and macro vascular disease in Africa. J Cardiovasc Risk 10:97–102CrossRefPubMed
3.
go back to reference Mufunda J, Nyarango P, Kosia A, Ogbamariam A, Mebrahtu G, Usman A et al (2005) Non-communicable diseases in Africa: a silent hypertension epidemic in Eritrea. J Hum Hypertens 19:255–256PubMed Mufunda J, Nyarango P, Kosia A, Ogbamariam A, Mebrahtu G, Usman A et al (2005) Non-communicable diseases in Africa: a silent hypertension epidemic in Eritrea. J Hum Hypertens 19:255–256PubMed
4.
go back to reference Mufunda J, Chatora R, Ndambakuwa Y, Nyarango P, Kosia A, Chifamba J et al (2006) Emerging non-communicable disease epidemic in Africa: preventive measures from the WHO Regional Office for Africa. Ethn Dis 16:521–526PubMed Mufunda J, Chatora R, Ndambakuwa Y, Nyarango P, Kosia A, Chifamba J et al (2006) Emerging non-communicable disease epidemic in Africa: preventive measures from the WHO Regional Office for Africa. Ethn Dis 16:521–526PubMed
5.
go back to reference Usman A, Mebrahtu G, Mufunda J, Nyarango P, Hagos G, Kosia A et al (2006) Prevalence of non communicable disease risk factors in Eritrea. Ethn Dis 16:542–546PubMed Usman A, Mebrahtu G, Mufunda J, Nyarango P, Hagos G, Kosia A et al (2006) Prevalence of non communicable disease risk factors in Eritrea. Ethn Dis 16:542–546PubMed
6.
go back to reference Mufunda J, Mebrahtu G, Usman A, Nyarango P, Kosia A, Ghebrat Y, Ogbamariam A, Masjuan M, Gebremichael A (2006) Prevalence of hypertension in Eritrea and its relationship with obesity: results from a national blood pressure survey. J Hum Hypertens 20(1):59–65CrossRefPubMed Mufunda J, Mebrahtu G, Usman A, Nyarango P, Kosia A, Ghebrat Y, Ogbamariam A, Masjuan M, Gebremichael A (2006) Prevalence of hypertension in Eritrea and its relationship with obesity: results from a national blood pressure survey. J Hum Hypertens 20(1):59–65CrossRefPubMed
7.
go back to reference Sharp P, Rainbow S (2002) Continuous glucose monitoring and hemoglobin A1C. Ann Clin Biochem 39:516–517CrossRefPubMed Sharp P, Rainbow S (2002) Continuous glucose monitoring and hemoglobin A1C. Ann Clin Biochem 39:516–517CrossRefPubMed
8.
go back to reference Manley S (2003) Haemoglobin A1c—a marker for complications of type 2 diabetes: the experience from the UK Prospective Diabetes Study (UKPDS). Clin Chem Lab Med 41:1182–1190CrossRefPubMed Manley S (2003) Haemoglobin A1c—a marker for complications of type 2 diabetes: the experience from the UK Prospective Diabetes Study (UKPDS). Clin Chem Lab Med 41:1182–1190CrossRefPubMed
9.
go back to reference Carinci F, Federici MO, Benedetti MM (2006) Diabetes registers and prevention strategies: towards an active use of health information. Diabetes Res Clin Pract 74(Suppl 2):S215–S219CrossRef Carinci F, Federici MO, Benedetti MM (2006) Diabetes registers and prevention strategies: towards an active use of health information. Diabetes Res Clin Pract 74(Suppl 2):S215–S219CrossRef
10.
go back to reference Georgioou A, Burns J, McKenzie S, Penn D, Flack J, Harris MF (2006) Monitoring change in diabetes care using diabetes registers-experience from divisions of general practice. Aust Fam Phys 35:77–80 Georgioou A, Burns J, McKenzie S, Penn D, Flack J, Harris MF (2006) Monitoring change in diabetes care using diabetes registers-experience from divisions of general practice. Aust Fam Phys 35:77–80
11.
go back to reference Abdul-Ghani M, Nawaf G, Nawaf F, Itzhak B, Minuchin O, Vardi P (2006) Increased prevalence of micro vascular complications in type 2 diabetes patients with the metabolic syndrome. Isr Med Assoc J 8:424–425 Abdul-Ghani M, Nawaf G, Nawaf F, Itzhak B, Minuchin O, Vardi P (2006) Increased prevalence of micro vascular complications in type 2 diabetes patients with the metabolic syndrome. Isr Med Assoc J 8:424–425
12.
go back to reference Swai AB, Kitange HM, Masuki G, Kilima PM, Alberti KG, McLarty DG (1992) Is diabetes mellitus related to undernutrition in rural Tanzania? BMJ 305:1057–1062CrossRefPubMed Swai AB, Kitange HM, Masuki G, Kilima PM, Alberti KG, McLarty DG (1992) Is diabetes mellitus related to undernutrition in rural Tanzania? BMJ 305:1057–1062CrossRefPubMed
13.
go back to reference Cuissnier-Raynall JC, Ducorps M, Grandpierre G (1985) Tropical diabetes mellitus, a new nutritional indicator. Med Trop 45:179–184 Cuissnier-Raynall JC, Ducorps M, Grandpierre G (1985) Tropical diabetes mellitus, a new nutritional indicator. Med Trop 45:179–184
14.
go back to reference Sleight P, Pouleur H, Zannad F (2006) Benefits, challenges, and registrability of the polypill. Eur Heart J 27:1651–1656CrossRefPubMed Sleight P, Pouleur H, Zannad F (2006) Benefits, challenges, and registrability of the polypill. Eur Heart J 27:1651–1656CrossRefPubMed
15.
go back to reference Gaziano TA, Opie LH, Weinsterin MC (2006) Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis. Lancet 368:679–686CrossRefPubMed Gaziano TA, Opie LH, Weinsterin MC (2006) Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis. Lancet 368:679–686CrossRefPubMed
16.
go back to reference Siraj ES, Sevoum B, Saenz C, Abdulkadir J (2006) Lipid and lipoprotein profiles in Ethiopians with diabetes mellitus. Metabolism 55:706–710CrossRefPubMed Siraj ES, Sevoum B, Saenz C, Abdulkadir J (2006) Lipid and lipoprotein profiles in Ethiopians with diabetes mellitus. Metabolism 55:706–710CrossRefPubMed
17.
go back to reference Kulenovic I, Rasic S, Karcic S (2006) Development of micro vascular complications in type 1 diabetic patients 10 years follow up. Bosn J Basic Med Sci 6:47–50PubMed Kulenovic I, Rasic S, Karcic S (2006) Development of micro vascular complications in type 1 diabetic patients 10 years follow up. Bosn J Basic Med Sci 6:47–50PubMed
18.
go back to reference Sokolnicki LA, Roberts SK, Wilkins BW, Basu A, Charkoudian N (2007) Contribution of nitric oxide to cutaneous micro vascular dilation in individuals with type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 292:E314–E318CrossRefPubMed Sokolnicki LA, Roberts SK, Wilkins BW, Basu A, Charkoudian N (2007) Contribution of nitric oxide to cutaneous micro vascular dilation in individuals with type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 292:E314–E318CrossRefPubMed
19.
go back to reference Kasaloya Z, Prazny M, Skrha J (2006) Relationship between peripheral diabetic neuropathy and micro vascular reactivity in patients with type 1 and type 2 diabetes mellitus—neuropathy and microcirculation. Exp Clin Endocrinol Diabet 114:52–57CrossRef Kasaloya Z, Prazny M, Skrha J (2006) Relationship between peripheral diabetic neuropathy and micro vascular reactivity in patients with type 1 and type 2 diabetes mellitus—neuropathy and microcirculation. Exp Clin Endocrinol Diabet 114:52–57CrossRef
20.
go back to reference Ogbera AO, Fasanmade O, Ohwovoriole AE, Adediran O (2006) An assessment of the disease burden of foot ulcers in patients with diabetes mellitus attending a teaching hospital in Lagos, Nigeria. Int J Low Extrem Wounds 5:244–249CrossRefPubMed Ogbera AO, Fasanmade O, Ohwovoriole AE, Adediran O (2006) An assessment of the disease burden of foot ulcers in patients with diabetes mellitus attending a teaching hospital in Lagos, Nigeria. Int J Low Extrem Wounds 5:244–249CrossRefPubMed
Metadata
Title
Profile of patients with diabetes in Eritrea: results of first phase registry analyses
Authors
Berhane Seyum
Goitom Mebrahtu
Abdulmumini Usman
Jacob Mufunda
Beyene Tewolde
Solomon Haile
Andrew Kosia
Ermias Negassi
Publication date
01-03-2010
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 1/2010
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-009-0093-8

Other articles of this Issue 1/2010

Acta Diabetologica 1/2010 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.